Melanie Schroeder

3.8k total citations · 1 hit paper
37 papers, 3.0k citations indexed

About

Melanie Schroeder is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Melanie Schroeder has authored 37 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Melanie Schroeder's work include Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Inhalation and Respiratory Drug Delivery (10 papers) and Asthma and respiratory diseases (7 papers). Melanie Schroeder is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Inhalation and Respiratory Drug Delivery (10 papers) and Asthma and respiratory diseases (7 papers). Melanie Schroeder collaborates with scholars based in United States, United Kingdom and Canada. Melanie Schroeder's co-authors include Donald F. Hunt, Jeffrey Shabanowitz, Joshua J. Coon, John E. P. Syka, Jae C. Schwartz, Thomas W. Sturgill, Carol A. Chrestensen, Mark Worthington, Jared W. Pelo and Donna J. Webb and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Melanie Schroeder

34 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry

2004 1.9k citations Melanie Schroeder, Jeffrey Shabanowitz et al. profile →

Peers

Countries citing papers authored by Melanie Schroeder

Since Specialization

Citations

This map shows the geographic impact of Melanie Schroeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Schroeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Schroeder more than expected).

Fields of papers citing papers by Melanie Schroeder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Schroeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Schroeder. The network helps show where Melanie Schroeder may publish in the future.

Co-authorship network of co-authors of Melanie Schroeder

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Schroeder. A scholar is included among the top collaborators of Melanie Schroeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Schroeder. Melanie Schroeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nasal High Flow With Asymmetrical Cannula: Effects on the Neural Respiratory Drive and the Ventilation in COPD Patients During Acute Exacerbation 2025 ·American Journal of Respiratory and Critical Care Medicine ·Georg Nilius, Melanie Schroeder, (unknown), U Domanski, Stanislav Tatkov	0
2	Prevalence of people living with multidrug‐resistant HIV and limited treatment options in Spain 2024 ·HIV Medicine ·Josep M. Llibre, Féderico García, José Luís Blanco, (unknown), (unknown), Luis Eduardo López-Cortés, Marta Montero, (unknown), Melanie Schroeder, (unknown), (unknown)	1
3	Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain 2023 ·Infectious Diseases and Therapy ·Santiago Moreno, Antonio Rivero, (unknown), Vicenç Falcó, Miguel Torralba, Melanie Schroeder, (unknown), (unknown), (unknown), (unknown), (unknown)	6
4	Comparative Efficacy and Safety of Fostemsavir in Heavily Treatment-Experienced People With HIV-1 2022 ·Clinical Therapeutics ·Sarah‐Jane Anderson, (unknown), (unknown), (unknown), Andrew Clark, (unknown), Melanie Schroeder	2
5	Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial 2021 ·ERJ Open Research ·Alan Martin, Dhvani Shah, (unknown), (unknown), (unknown), Melanie Schroeder, Nancy Risebrough, Afisi Ismaila	6
6	Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK 2020 ·ERJ Open Research ·Elisabeth Fenwick, Alan Martin, Melanie Schroeder, Stuart Mealing, (unknown), Nancy Risebrough, Afisi Ismaila	12
7	<p>Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective</p> 2020 ·International Journal of COPD ·Melanie Schroeder, (unknown), (unknown), (unknown), Alan Martin, (unknown), José Luís Izquierdo Alonso, Juan Antonio Riesco, Juan José Soler‐Cataluña, Alicia Huerta, Afisi Ismaila	11
8	Treatment Preferences of Patients with Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups in the United Kingdom, United States, and Germany 2020 ·Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ·Melanie Schroeder, (unknown), Lina Eliasson, (unknown), Necdet B. Gunsoy, Jake Macey, Paul Jones, Afisi Ismaila	5
9	<p>Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany</p> 2020 ·International Journal of COPD ·Hannah B Lewis, Melanie Schroeder, Necdet B. Gunsoy, Ellen M. Janssen, (unknown), Helen Doll, Paul Jones, Afisi Ismaila	9
10	Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Melanie Schroeder, (unknown), Alan Martin, (unknown), (unknown), Gerard J. Criner, Mark T. Dransfield, (unknown), (unknown), (unknown)	0
11	PRS25 THE IMPACT TRIAL: IS SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) COST-EFFECTIVE VERSUS DUAL THERAPY WITH INHALED CORTICOSTEROID PLUS LONG-ACTING BETA AGONIST (FF/VI) IN PATIENTS WITH COPD IN SPAIN? 2019 ·Value in Health ·(unknown), (unknown), Melanie Schroeder, Alan Martin, José Luís Izquierdo Alonso, José Miranda, (unknown), Nancy Risebrough, (unknown), (unknown), Afisi Ismaila	1
12	PRS24 COMPARISON OF TWO ECONOMIC MODELS IN THE EVALUATION OF THE COST-EFFECTIVENESS OF TRIPLE THERAPY TREATMENT FOR ADVANCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 2019 ·Value in Health ·Timothy Baker, Alan Martin, (unknown), Melanie Schroeder, (unknown), Afisi Ismaila	1
13	<p>Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial</p> 2019 ·International Journal of COPD ·Afisi Ismaila, Nancy Risebrough, Melanie Schroeder, Dhvani Shah, Alan Martin, Emma C Goodall, (unknown), Gerard J. Criner, Mark T. Dransfield, David Halpin, MeiLan K. Han, David A. Lomas	24
14	CE2 - COST-EFFECTIVENESS OF A NEW SINGLE INHALER TRIPLE THERAPY VERSUS A DUAL INHALED CORTICOSTEROID PLUS LONG-ACTING BETA AGONIST IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN 2018 ·Value in Health ·(unknown), Alicia Huerta, (unknown), Melanie Schroeder, (unknown), (unknown), (unknown), José Miranda, Alan Martin, (unknown), Afisi Ismaila	1
15	PRS39 - COST-EFFECTIVENESS OF A NEW SINGLE INHALER TRIPLE THERAPY (SITT) VERSUS MULTIPLE INHALER TRIPLE THERAPIES (MITT) TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN CANADA 2018 ·Value in Health ·Emma C Goodall, Melanie Schroeder, Greta Lozano‐Ortega, Karissa Johnston, Alan Martin, (unknown)	2
16	p53 isoform profiling in glioblastoma and injured brain 2012 ·Oncogene ·Rie Takahashi, Caterina Giannini, Jann N. Sarkaria, Melanie Schroeder, Jack T. Rogers, Diego Mastroeni, Heidi Scrable	44
17	Inhibition of tristetraprolin deadenylation by poly(A) binding protein 2008 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·(unknown), Carol A. Chrestensen, Melanie Schroeder, (unknown), Jared W. Pelo, Jeffery Shabanowitz, Robert DeRose, Donald F. Hunt, Thomas W. Sturgill, Mark Worthington	15
18	Methods for the Detection of Paxillin Post-translational Modifications and Interacting Proteins by Mass Spectrometry 2005 ·Journal of Proteome Research ·Melanie Schroeder, Donna J. Webb, Jeffrey Shabanowitz, Alan F. Horwitz, Donald F. Hunt	56
19	MAPKAP Kinase 2 Phosphorylates Tristetraprolin on in Vivo Sites Including Ser178, a Site Required for 14-3-3 Binding 2004 ·Journal of Biological Chemistry ·Carol A. Chrestensen, Melanie Schroeder, Jeffrey Shabanowitz, Donald F. Hunt, Jared W. Pelo, Mark Worthington, Thomas W. Sturgill	230
20	Stoichiometry of the Large Conductance Bacterial Mechanosensitive Channel of E. coli. A Biochemical Study 1999 ·The Journal of Membrane Biology ·Sergei Sukharev, Melanie Schroeder, Darrell R. McCaslin	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact